Oncternal And SpringWorks Among Early ASCO Winners And Losers

SpringWorks Declines Despite Positive Results

 
• By Andrew McConaghie
Nasdaq
Many NASDAQ-listed biotech companies are in need of a share price bounce, which are hard to come by in the current market. • Source: Alamy

More from Anticancer

More from Therapeutic Category